HAE
Haemonetics Corporation
106.80$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.2% | -0.2% | 18.7% | -8.2% | 14.1% | 12.6% | 35.3% | 5.4% | 34.0% | 27.6% | 20.5% | 15.4% | 24.3% | |
| 7.2% | 7.0% | 8.1% | 8.7% | 8.5% | 8.3% | 8.5% | 8.9% | 8.6% | 8.1% | 7.9% | 8.0% | 8.1% | |
| 2.1% | 2.1% | 2.2% | 2.3% | 2.0% | 2.4% | 2.1% | 2.9% | 2.3% | 2.3% | 2.6% | 2.7% | 2.5% | |
| 5.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.9% | -19.9% | 3.7% | -24.6% | -7.9% | -10.1% | 12.4% | -17.3% | 8.0% | 3.5% | -1.8% | -2.0% | 1.9% | |
| 7.7% | 6.6% | 2.8% | 1.7% | 2.7% | 2.5% | 4.7% | 1.2% | 1.5% | 1.9% | 5.1% | 2.3% | 2.7% | |
| -7.9% | -80.0% | -3.8% | -41.4% | -6.8% | -5.0% | 5.5% | -10.3% | -9.3% | -8.7% | -25.0% | -6.6% | -12.5% | |
| 1.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.4% | -1.8% | -1.7% | -2.9% | -21.7% | -2.8% | -45.4% | -1.5% | -22.9% | 22.1% | -28.9% | -1.0% | -7.7% | |
| -1.1% | – | – | – | 0.0% | -0.4% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -15.2% | -4.2% | |
| -2.3% | 32.5% | -18.5% | 99.3% | -21.7% | 0.4% | -45.8% | -0.8% | -23.4% | 0.6% | -29.3% | -15.2% | -16.8% | |
| 20.5% | -46.7% | -4.4% | 49.3% | -13.1% | 6.2% | -4.3% | -4.3% | 1.1% | 19.7% | -34.0% | -6.5% | -5.1% | |
| 23.4% | -6.8% | 15.8% | -9.8% | 11.4% | 10.1% | 30.5% | 4.2% | 32.5% | 25.7% | 15.4% | 13.1% | 21.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.